Home › Funds › EVENTIDE ASSET MANAGEMENT, LLC › TRVI

EVENTIDE ASSET MANAGEMENT, LLC position in TRVI

TREVI THERAPEUTICS INC COM · Health Care

EVENTIDE ASSET MANAGEMENT, LLC reported holding 2,660,000 shares of TRVI (TREVI THERAPEUTICS INC COM) in its Q2 2026 13F filing — a position valued at US$49.6M, representing 0.66% of its reported portfolio and ranking #48 among its reported holdings. EVENTIDE ASSET MANAGEMENT, LLC has disclosed TRVI holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)2.66M sh
Reported value held$49.61M
Portfolio Weight0.66%
First reportedQ2 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How EVENTIDE ASSET MANAGEMENT, LLC's TRVI position evolved

EVENTIDE ASSET MANAGEMENT, LLC first disclosed a stake in TRVI in Q2 2025 at 1,381,324 shares (US$7.6M). The position peaked in Q2 2026 at 2,660,000 shares, worth US$49.6M. Across 5 filings, EVENTIDE ASSET MANAGEMENT, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 2,660,000 shares valued at US$49.6M — an increase of 37,694 shares quarter over quarter.. Notable position changes include a 90% increase in Q4 2025 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 1.38M $7.56M New
Q3 2025 1.38M $12.64M Hold
Q4 2025 2.62M $32.83M Add
Q1 2026 2.62M $31.28M Hold
Q2 2026 2.66M $49.61M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TRVI and 13F data

TRVI (TREVI THERAPEUTICS INC COM) is a Health Care company. 64 other funds we track also report a position in TRVI — the largest reported positions include NEA Management Company, LLC (US$246.6M), Frazier Life Sciences Management, L.P. (US$185.4M), Vivo Capital, LLC (US$95.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TRVI

All TRVI fund holders →

FAQ

How long has EVENTIDE ASSET MANAGEMENT, LLC held TRVI?

EVENTIDE ASSET MANAGEMENT, LLC has disclosed TRVI holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is EVENTIDE ASSET MANAGEMENT, LLC's current position in TRVI?

As of Q2 2026, EVENTIDE ASSET MANAGEMENT, LLC holds 2.66M shares of TRVI (TREVI THERAPEUTICS INC COM), valued at $49.61M, representing 0.66% of its reported portfolio and ranking #48.

Has EVENTIDE ASSET MANAGEMENT, LLC been buying or selling TRVI?

In the latest 13F filing (Q2 2026), EVENTIDE ASSET MANAGEMENT, LLC increased its position in TRVI. The position peaked in Q2 2026 at 2.66M shares.

Which other funds hold TRVI?

Other major institutional holders of TRVI include NEA Management Company, LLC, Frazier Life Sciences Management, L.P., Vivo Capital, LLC, among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.